DSIJ Mindshare

Shilpa Medicare joins hands with Dr Reddy's Laboratories for production-supply of Sputnik V vaccine

Apurva Joshi 0 609 Article rating: 4.9

Shilpa Medicare Limited via its wholly-owned subsidiary, Shilpa Biologicals Private Limited (SBPL) has entered into a three-year definitive agreement with Dr Reddy's Laboratories Limited (DRL) for production-supply of Sputnik V vaccine (used for COVID-19) from its integrated biologics R&D-cum-manufacturing centre at Dharwad (Karnataka).

RSS
First30793080308130823084308630873088Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR